Sinchita Roy-Chowdhuri
Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
False
Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
What gaps in technology/training/processes concern you most, and how are you addressing them via innovation?
No Patient Left Behind
Current therapeutic management of patients with solid tumors is largely dependent on molecular diagnostics and being able to identify genomic alterations in tissue specimens that drive precision oncology. In patients with advanced stage malignancies where diagnoses are typically made on small specimens, 10–20 percent of patients cannot get molecular profiling due to insufficient tumor samples.
Our group has focused on leveraging supernatant samples from patient’s cytology specimens to extract nucleic acids that can be used to perform next generation sequencing. By repurposing an otherwise discarded substrate, we can now offer patients who do not have adequate tumor samples an alternative testing option that allows for treatment decisions without the need for an additional repeat biopsy.
We have demonstrated the feasibility of this testing option in several studies and have recently published the analytical validation of a rapid one-day NGS assay using an otherwise discarded byproduct of cytologic specimen processing, making the reality of precision medicine available to more patients.
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

False
False
Affiliations:
Specialties:
Areas of Expertise:
False